Literature DB >> 1611460

Reduction of mucosal crypt cell proliferation in patients with colorectal adenomatous polyps by dietary calcium supplementation.

G H Barsoum1, C Hendrickse, M C Winslet, D Youngs, I A Donovan, J P Neoptolemos, M R Keighley.   

Abstract

The crypt cell production rate was measured in 14 patients with adenomatous colorectal polyps, 17 patients with colorectal cancer and 12 control subjects. The median (interquartile range) rate (cells per crypt per hour) was found to be significantly higher (P less than 0.001) in the polyp (2.45 (1.94-3.20)) and cancer (3.01 (2.35-3.68)) groups compared with controls (1.25 (0.70-1.85)). A double-blind cross-over study was performed in patients with adenomatous polyps consisting of 2 months' treatment, 2 weeks' washout, followed by 2 months' treatment with dietary calcium supplementation (1.25 g day-1) versus placebo. A significant reduction in the crypt cell production rate occurred with calcium treatment compared with the placebo (1.25 (0.6-2.25) versus 2.15 (1.58-3.08) cells per crypt per hour, P = 0.035). This study demonstrates a significant reduction in mucosal cell proliferation by dietary calcium supplementation in patients with adenomatous polyps. Such treatment may be worthy of further investigation in patients at high risk of developing colorectal polyps.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1611460     DOI: 10.1002/bjs.1800790639

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Nutritional strategies in the prevention of colorectal cancer.

Authors:  J B Mason; Y i Kim
Journal:  Curr Gastroenterol Rep       Date:  1999-08

2.  Dietary calcium does not reduce experimental colorectal carcinogenesis after small bowel resection despite reducing cellular proliferation.

Authors:  G H Barsoum; H Thompson; J P Neoptolemos; M R Keighley
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

3.  Effect of longterm placebo controlled calcium supplementation on sigmoidal cell proliferation in patients with sporadic adenomatous polyps.

Authors:  U M Weisgerber; H Boeing; R W Owen; R Waldherr; R Raedsch; J Wahrendorf
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

4.  Calcium and colorectal epithelial cell proliferation.

Authors:  J H Kleibeuker; N H Mulder; A Cats; R van der Meer; E G de Vries
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

5.  Divergent effects of epidermal growth factor and calcipotriol on human rectal cell proliferation.

Authors:  M G Thomas; G R Brown; M R Alison; R C Williamson
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

6.  Luminal and humoral influences on human rectal epithelial cytokinetics.

Authors:  M G Thomas
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

7.  The effect of calcium supplements on rectal mucosal proliferation.

Authors:  N C Armitage; P S Rooney; K A Gifford; P A Clarke; J D Hardcastle
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

8.  The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR).

Authors:  P S Rooney; P A Clarke; K A Gifford; J D Hardcastle; N C Armitage
Journal:  Br J Cancer       Date:  1993-07       Impact factor: 7.640

9.  Epithelial cell proliferation in the sigmoid colon of patients with adenomatous polyps increases during oral calcium supplementation.

Authors:  J H Kleibeuker; J W Welberg; N H Mulder; R van der Meer; A Cats; A J Limburg; W M Kreumer; M J Hardonk; E G de Vries
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.